1. Home
  2. UIS vs ORMP Comparison

UIS vs ORMP Comparison

Compare UIS & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

SELL

Current Price

$2.21

Market Cap

208.5M

Sector

Technology

ML Signal

SELL

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

SELL

Current Price

$4.24

Market Cap

197.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
UIS
ORMP
Founded
1942
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.5M
197.6M
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
UIS
ORMP
Price
$2.21
$4.24
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $4.81
N/A
AVG Volume (30 Days)
★ 587.8K
156.9K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
★ 5.77%
EPS Growth
N/A
★ 412.50
EPS
N/A
★ 2.76
Revenue
★ $1,950,100,000.00
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.84
N/A
P/E Ratio
★ N/A
$1.57
Revenue Growth
N/A
★ 49.25
52 Week Low
$1.97
$2.09
52 Week High
$4.98
$5.47

Technical Indicators

Market Signals
Indicator
UIS
ORMP
Relative Strength Index (RSI) 32.99 36.04
Support Level $2.14 $3.91
Resistance Level $2.61 $4.52
Average True Range (ATR) 0.09 0.16
MACD 0.01 -0.05
Stochastic Oscillator 13.55 14.67

Price Performance

Historical Comparison
UIS
ORMP

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Share on Social Networks: